PositiveSingles.com - the best, most trusted and largest anonymous STD dating site!

Herpes Survival Kit - a specially designed pack containing everything you need to combat herpes and cold sore outbreaks (at a minimum cost to your wallet).

only search Racoon.com

"The Good News about the Bad News - 
Herpes: Everything You Need to Know
"  
Terri Warren's new book - which we do endorse.

First time visitor? Please Learn about Registering and read our policy page.
{Home}{Awareness}{Research}{Treatment}{HHP FAQ}{Bookstore}{Bio/Info Page}

The Original Herpes Home Page Discussion Forums

Subject: "Merck does not get approval from FDA: HPV vaccine for those over 27"     Previous Topic | Next Topic
Printer-friendly copy     Email this topic to a friend    
Conferences HPV (Human Papilloma Virus) Topic #974
Reading Topic #974
muffinadmin
Member since Sep-10-04
6230 posts
Apr-09-11, 02:55 PM (CST)
Click to EMail muffin Click to send private message to muffin Click to view user profileClick to add this user to your buddy list  
"Merck does not get approval from FDA: HPV vaccine for those over 27"
 
http://www.nj.com/business/index.ssf/2011/04/merck_fails_to_get_approval_to.html

Merck fails to get approval to market Gardasil to women older than 27 for protection against HPV virus

Published: Wednesday, April 06, 2011, 7:00 PM Updated: Wednesday, April 06, 2011, 7:07 PM
By Bloomberg News

The Associated Press
Merck failed in its effort to win regulatory approval to market Gardasil as a protection against the HPV virus and cervical cancer to women between the ages of 27 and 45.

Federal drug regulators failed to grant Merck approval to expand the use of its cervical-cancer vaccine Gardasil to older women, the company said in a statement posted on its website.

Merck, which is based in Whitehouse Station, had sought approval from the Food and Drug Administration to market the vaccine to women between the ages of 27 and 45.

Gardasil is sold as a prevention against human papillomavirus infections, which can cause cervical cancer and genital warts. The vaccine won FDA approval in 2006 for use in female patients ages 9 to 26, and was cleared for males in that age group in 2009.

The vaccine generated $988 million in sales in 2010, a decrease of 12 percent from 2009, according to company filings.

In 2008, federal regulators granted a six-month expedited review of Merckís application to expand Gardasilís use to older women. The agency delayed its decision three times as it sought more information from the company.


  Alert | IP Printer-friendly page | Edit | Reply | Reply With Quote | Top
Rajahadmin
Charter Member
15328 posts
Apr-19-11, 11:29 PM (CST)
Click to EMail Rajah Click to send private message to Rajah Click to view user profileClick to add this user to your buddy list  
1. "This makes no sense to me..."
In response to message #0
 
I believe that there's nothing stopping a doctor from providing it to women older than 27, but I guess they can't market it that way, if I understand correctly.

"Do the Right Thing. It will gratify some people and astound the rest." - Paraphrased from Mark Twain


  Alert | IP Printer-friendly page | Edit | Reply | Reply With Quote | Top

Conferences | Topics | Previous Topic | Next Topic

 

Advertisements appearing on this page do not constitute any endorsement of 
those products or services by HHP or its management.

All opinions expressed here by the HHP, its management and participants constitute just that, opinions.
No medical relationship with any participant is implied in any way.
Each individual's personal doctor is responsible for the medical advice and care of that person.